Cargando…
Mechanisms of resistance to EGFR-targeted therapies in colorectal cancer: more than just genetics
The development of acquired resistance to anti-EGFR therapies remains poorly understood, with most research to date exploring, and trying to overcome, various genomic mechanisms of resistance. However, recent work supports a model of resistance whereby transcriptomic mechanisms of resistance predomi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542118/ https://www.ncbi.nlm.nih.gov/pubmed/37791069 http://dx.doi.org/10.3389/fcell.2023.1176657 |